Korea

Seoul's New Neighbor: Toko Kopi Tuku Unites Indonesian Tradition with Korean Vibrancy at New Pop-Up Shop

SEOUL, South Korea, March 26, 2024 /PRNewswire/ -- Embracing the rich coffee culture ofSouth Korea, Toko Kopi Tuku (TUKU), the Indonesian coffee brand beloved for its iced coffee, is thrilled to launch the first pop-up coffee shop in the heart ofSeoul's bustling Gangnam district. The shop will be...

2024-03-27 08:38 853

Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology

SEONGNAM, South Korea and AURORA, Colo., March 26, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330) , a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr.Raul...

2024-03-27 06:00 370

SÉZANNE IN TOKYO CLAIMS NO.1 SPOT AT ASIA'S 50 BEST RESTAURANTS 2024

* Tokyo's Sézanne climbs to the top spot to be awarded The Best Restaurant in Asia, sponsored by S.Pellegrino & Acqua Panna * Singapore leads the rankings with nine entries, and welcomes newcomers  Seroja(No.31), also the winner of the Highest New Entry Award 2024, sponsored by Nongshim, and L...

2024-03-27 00:05 630

EIPGRID Acquires FE and Ventures into 'VPP+EaaS' Business

* EIPGRID, a renowned global provider of community energy solutions, embarks on a groundbreaking initiative by launching its own community energy service in Jeju Island, Korea. * This marks the first step and a significant leap towards establishing the innovative 'VPP+EaaS' business ecosystem...

2024-03-27 00:00 310

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

- New research published in Clinical Cancer Research shows significant improvement in distant recurrence-free survival with combined durvalumab and tremelimumab treatment, supported by Lunit SCOPE IO's analysis of tumor microenvironment SEOUL, South Korea, March 26, 2024 /PRNewswire/ -- Lunit (K...

2024-03-26 21:00 713

TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710, a Long-acting Recombinant Activated Factor VII, in Hemophilia A or B Patients

* TU7710 has the potential to be a highly effective and long-acting treatment for bleeding episodes as well as for preventing bleeding during surgery or invasive procedures in hemophilia patients with inhibitors * Interim results from an ongoing Phase 1a study in healthy male volunteers will ...

2024-03-26 20:00 693

BioDuro-Sundia's Partner, DigmBio Announced IND Clearance from Korea MFDS for its Selective PARP1 Inhibitor DM5167

SHANGHAI, March 26, 2024 /PRNewswire/ -- BioDuro-Sundia's partner, DigmBio, a South Korean biotechnology company, announced its selective PARP1 inhibitor for the treatment of triple-negative breast cancer has been approved by Korea Food and Drug Administration (MFDS) for Investigational New Drug ...

2024-03-26 08:30 1049

Zambia External Bondholder Steering Committee Reaches Agreement with Zambia on Debt Restructuring

LONDON, March 25, 2024 /PRNewswire/ -- The Zambia External Bondholder Steering Committee (the "Committee") is pleased to announce that it has reached a conclusive agreement (the "2024 Agreement") with the Government of Zambia (the " Government") on a restructuring of Zambia's (i) US$750,000,000 5....

2024-03-25 23:39 1509

GC Genome to Present New Data at AACR 2024

Offering Hope for Enhanced Early Detection and Patient Care in the Battle Against Cancer YONGIN, South Korea, March 25, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that the company will present two poster presentations at the American Association fo...

2024-03-25 21:00 1232

Squirrel Ai showcases L5-level Large Adaptive Model at AI Summit Seoul

The AI adaptive education Unicorn company engages in forward-looking discussions on AI's future with industry giants SEOUL, South Korea, March 25, 2024 /PRNewswire/ -- Dr. Joleen Liang, the co-founder of Squirrel Ai Learning, took the stage as a keynote speaker at the 6th AI Summit Seoul, a pres...

2024-03-25 19:06 1183

HYUNDAI TRANSYS Triumphs with Two Awards at "iF DESIGN AWARD 2024"

* Double Win in "Urban Air Mobility Cabin Concept" and "Future Mobility Concept Seat" * First in the Domestic Automotive Parts Industry to Set Direction for UAM Space, Proving Global Design Competence HANOVER, Germany and SEOUL, South Korea, March 25, 2024 /PRNewswire/ -- HYUNDAI TRANSYS, a le...

2024-03-25 08:50

Hancom announces strategic investment in Spanish AI biometric company FacePhi

* Hancom acquires exclusive business rights to FacePhi in APAC region * Hancom to establish bridgehead for entering the overseas AI market by selling under Hancom brand (white labeling) * FacePhi holds facial recognition technology with world-class security BARCELONA and SEOUL, South Korea,...

2024-03-25 07:00

JA Solar Completes First Delivery under the MOU Agreement with South Korea's SK E&S for 200MW n-Type Modules

BEIJING, March 22, 2024 /PRNewswire/ -- JA Solar, a leading manufacturer of high-performance photovoltaic (PV) products, recently completed the delivery of the first batch of 5.2MW modules under the memorandum of understanding (MOU) agreement with SK Group's subsidiary, SK E&S, for 200MW n-type m...

2024-03-22 14:09 2104

Tripbtoz Unveils Revolutionary Travel-to-Earn Service at SXSW 2024

- Blending virtual and real travel into a unified experience - " In tune with K-culture's popularity, we aim to unite diverse cultures and people " SEOUL, South Korea, March 22, 2024 /PRNewswire/ -- Tripbtoz (CEO Jiha Jung) announced that it participated in South by Southwest 2024 (SXSW 2024) inA...

2024-03-22 13:23 1287

GLN International, Signs MOU with Fonepay to explore possible collaboration opportunities for cross-border QR payment between Korea and Nepal

SEOUL, South Korea, March 22, 2024 /PRNewswire/ -- GLN International (Kyungho Kim, CEO), a global payment network provider company, announced that it signed an MOU with Fonepay Payment Service Ltd,Nepal's largest payment network, to explore opportunities to integrate its system to provide cross-b...

2024-03-22 09:00 2331

BANF Smart Tire collaborates with CampX by Volvo Group

Collaboration Redefining Intelligent Tire Technology Efficacy. SEOUL, South Korea, March 21, 2024 /PRNewswire/ -- BANF, a leader in smart tire technology, collaborates with CampX by Volvo Group in a Proof of Value (PoV) project, co-creating on intelligent tire safety and fuel efficiency optimiza...

2024-03-22 08:01 1271

COSRX Returns to TikTok with the #PatThePeptide Campaign, Highlighting the Accessibility of Peptide Skincare

SEOUL, South Korea, March 22, 2024 /PRNewswire/ -- Building on the triumph of the #PrepPair challenge, which amassed an impressive viewership of over 49 million views, COSRX, a derm favorite skincare brand, is thrilled to unveil its latest TikTok campaign: the #PatThePeptide challenge.

2024-03-22 07:00 1820

COSRX Returns to TikTok with the #PatThePeptide Campaign, Highlighting the Accessibility of Peptide Skincare

SEOUL, South Korea, March 22, 2024 /PRNewswire/ -- Building on the triumph of the #PrepPair challenge, which amassed an impressive viewership of over 49 million views, COSRX, a derm favorite skincare brand, is thrilled to unveil its latest TikTok campaign: the #PatThePeptide challenge.

2024-03-22 07:00 1815

FDA Grants Orphan Drug Designation to Cevidoplenib for ITP

PANGYO, South Korea, March 21, 2024 /PRNewswire/ -- Oscotec Inc. has secured orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for its SYK inhibitor, Cevidoplenib, to treat immune thrombocytopenia (ITP). Oscotec has successfully completed phase 2 study in patients wit...

2024-03-21 20:00 1294

HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update

* Full-year 2023 net revenue reaches 135 billion KRW, driven by strong sales growth. * R&D momentum persisted with promising developments in anti-FcRn antibodies HL161ANS and batoclimab, positioning them as potentially best-in-class treatments for lgG-mediated autoimmune diseases. * Anticip...

2024-03-21 19:00 1119
12345678 ... 272